The forum addressed the main risks in the pharmaceutical supply chain, highlighting the critical importance of temperature control, traceability, and safety in the transport of medicines and biotechnological products. The role of insurers, brokers, and logistics operators in mitigating incidents was analyzed, with an emphasis on good distribution practices (GDP), training, and the use of real-time monitoring technology. Finally, the need for more informed and collaborative underwriting to expand coverage and reduce losses, especially due to temperature variations, was underscored.